Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
J Neurochem
    September 2025
  1. USENKO TS, Basharova KS, Bezrukova AI, Grigor'eva EV, et al
    Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1- and LRRK2-Associated Parkinson's Disease Patient-Derived Cells.
    J Neurochem. 2025;169:e70214.
    >> Share

    July 2025
  2. TNG TJW, Leow DMK, Goh G, Wang Z, et al
    Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models.
    J Neurochem. 2025;169:e70168.
    >> Share

    June 2025
  3. HO MS
    Clearance Pathways for alpha-Synuclein in Parkinson's Disease.
    J Neurochem. 2025;169:e70124.
    >> Share

  4. HUANG A, Foti RS, Gunawardana CG, Shen H, et al
    Bioanalytical Considerations for Biomarkers of Parkinson's Disease.
    J Neurochem. 2025;169:e70131.
    >> Share

    May 2025
  5. JING Y, Zhu H, Yao P, Chen Y, et al
    IgD-CD38-B Cell Partially Mediates the Protective Effect of Higher Serum Triacylglycerol (53:4) Levels Against Parkinson's Disease.
    J Neurochem. 2025;169:e70067.
    >> Share

    April 2025
  6. MUSTHAFA T, Nizami SK, Mishra A, Hasan G, et al
    Altered Mitochondrial Bioenergetics and Calcium Kinetics in Young-Onset PLA2G6 Parkinson's Disease iPSCs.
    J Neurochem. 2025;169:e70059.
    >> Share

    March 2025
  7. LI Y, Jiang J, Li J, Liu S, et al
    Exosome-Derived CDC42 From Hypoxia-Pretreated Neural Stem Cells Inhibits ACSL4-Related Ferroptosis to Alleviate Vascular Injury in Parkinson's Disease Mice Models.
    J Neurochem. 2025;169:e70027.
    >> Share

    February 2025
  8. PRATES-RODRIGUES M, Schweizer BLA, de Paula Gomes C, Ribeiro AM, et al
    Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.
    J Neurochem. 2025;169:e70008.
    >> Share

  9. POKHAREL PV, Newchurch AM, Overby SC, Spease CA, et al
    Oxidative Stress Suppresses Trk Signaling While Stimulating JNK-Mediated Endocytosis and Cleavage of p75(NTR): A Targetable Pathway for Neuroprotection in a Parkinson's Disease Model.
    J Neurochem. 2025;169:e70010.
    >> Share

  10. PICCOLI M, Barbato L, Maiorana NV, Mingione A, et al
    Direct Current Stimulation (DCS) Modulates Lipid Metabolism and Intercellular Vesicular Trafficking in SHSY-5Y Cell Line: Implications for Parkinson's Disease.
    J Neurochem. 2025;169:e70014.
    >> Share

    November 2024
  11. WITZIG V, Pjontek R, Tan SKH, Schulz JB, et al
    Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease.
    J Neurochem. 2024 Nov 18. doi: 10.1111/jnc.16264.
    >> Share

    October 2024

  12. RETRACTION: The oxysterol 27-hydroxycholesterol regulates alpha-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors-relevance to Parkinson's disease.
    J Neurochem. 2024 Oct 15. doi: 10.1111/jnc.16240.
    >> Share

    September 2024
  13. GOLDSTEIN DS, Sullivan P, Holmes C
    Cerebrospinal fluid concentration gradients of catechols in synucleinopathies.
    J Neurochem. 2024;168:2926-2934.
    >> Share

  14. ONAL G, Yalcin-Cakmakli G, Ozcelik CE, Boussaad I, et al
    Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.
    J Neurochem. 2024;168:2543-2560.
    >> Share

    June 2024
  15. ALVES BDS, Schimith LE, da Cunha AB, Dora CL, et al
    Omega-3 polyunsaturated fatty acids and Parkinson's disease: A systematic review of animal studies.
    J Neurochem. 2024 Jun 24. doi: 10.1111/jnc.16154.
    >> Share

    May 2024
  16. LI J, Ng KW, Sung CC, Chung KKK, et al
    The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.
    J Neurochem. 2024 May 1. doi: 10.1111/jnc.16122.
    >> Share

    March 2024
  17. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    >> Share

  18. PLACIDO E, Koss DJ, Outeiro TF, Brocardo PS, et al
    Altered hippocampal doublecortin expression in Parkinson's disease.
    J Neurochem. 2024 Mar 14. doi: 10.1111/jnc.16101.
    >> Share

  19. KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al
    Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human alpha-synuclein A53T transgenic mice during early adulthood.
    J Neurochem. 2024;168:269-287.
    >> Share

    January 2024
  20. CARMONA A, Carboni E, Gomes LC, Roudeau S, et al
    Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
    J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040.
    >> Share

    December 2023
  21. ZHANG F, Yang D, Li J, Du C, et al
    Synaptotagmin-11 regulates immune functions of microglia in vivo.
    J Neurochem. 2023;167:680-695.
    >> Share

  22. RENTSCH P, Egan T, Kuriakose A, Stayte S, et al
    The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias.
    J Neurochem. 2023;167:633-647.
    >> Share

    November 2023
  23. BILLINGS JL, Hilton JBW, Liddell JR, Hare DJ, et al
    Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.
    J Neurochem. 2023;167:337-346.
    >> Share

  24. SONG DY, Yuan L, Cui N, Feng C, et al
    alpha-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
    J Neurochem. 2023;167:461-484.
    >> Share

    September 2023
  25. WANG J, Joseph S, Vingill S, Dere E, et al
    Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain neurons in mice leads to abnormal motor behavior and synaptic defects.
    J Neurochem. 2023 Sep 27. doi: 10.1111/jnc.15962.
    >> Share

  26. MUHAMMAD B, Li H, Gu Y, Xue S, et al
    IL-1beta/IL-1R1 signaling is involved in the propagation of alpha-synuclein pathology of the gastrointestinal tract to the brain.
    J Neurochem. 2023;166:830-846.
    >> Share

  27. CHENG JY, Deng YT, Yu JT
    The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    J Neurochem. 2023;166:972-981.
    >> Share

    July 2023
  28. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
    Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
    J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
    >> Share

    June 2023
  29. GASPAROTTO J, Somensi N, Girardi CS, Bittencourt RR, et al
    Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    J Neurochem. 2023 Jun 28. doi: 10.1111/jnc.15890.
    >> Share

  30. HE H, Zhang Q, Liao J, Lei J, et al
    METTL14 is decreased and regulates m(6) A modification of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2023 Jun 13. doi: 10.1111/jnc.15882.
    >> Share

  31. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    >> Share

    April 2023
  32. MASUKAWA D, Kitamura S, Tajika R, Uchimura H, et al
    Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum.
    J Neurochem. 2023;165:177-195.
    >> Share

  33. BRONTESI L, Imberdis T, Ramalingam N, Dettmer U, et al
    The effects of KTKEGV repeat motif and intervening ATVA sequence on alpha-synuclein solubility and assembly.
    J Neurochem. 2023;165:246-258.
    >> Share

    February 2023
  34. CHEN YH, Kuo YY, You YQ, Lin YT, et al
    Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease.
    J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15794.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016